IRX 4647
Alternative Names: AGN 204647; IRX-4647Latest Information Update: 28 Nov 2023
At a glance
- Originator Io Therapeutics
- Class Antineoplastics; Small molecules
- Mechanism of Action Retinoic acid receptor gamma agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Non-small cell lung cancer